4//SEC Filing
Carvajal Alejandra 4
Accession 0001104659-25-004180
CIK 0001442836other
Filed
Jan 15, 7:00 PM ET
Accepted
Jan 16, 5:23 PM ET
Size
9.4 KB
Accession
0001104659-25-004180
Insider Transaction Report
Form 4
Carvajal Alejandra
SVP, Chief Legal Officer
Transactions
- Exercise/Conversion
Common Stock
2025-01-14+2,500→ 71,844 total - Exercise/Conversion
Restricted Stock Unit
2025-01-14−2,500→ 2,500 total→ Common Stock (2,500 underlying) - Sale
Common Stock
2025-01-15$0.63/sh−952$600→ 70,892 total
Footnotes (4)
- [F1]Represents shares of common stock received upon vesting of a portion of the restricted stock units ("RSUs") awarded to the Reporting Person on January 14, 2022.
- [F2]Represents the sale of shares of common stock to satisfy the Reporting Person's tax withholding obligations in connection with the service-based vesting and settlement of the RSUs pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 10, 2023. The sale was effected through an automatic "sell to cover" transaction that did not represent a discretionary trade by the Reporting Person.
- [F3]Each RSU represents the contingent right to receive one share of common stock of the Issuer.
- [F4]25% of the total number of RSUs granted vested on January 14, 2025, and the remainder shall vest on January 14, 2026.
Documents
Issuer
Mersana Therapeutics, Inc.
CIK 0001442836
Entity typeother
Related Parties
1- filerCIK 0001645755
Filing Metadata
- Form type
- 4
- Filed
- Jan 15, 7:00 PM ET
- Accepted
- Jan 16, 5:23 PM ET
- Size
- 9.4 KB